With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.607-01-2,Ethyldiphenylphosphine,as a common compound, the synthetic route is as follows.
General procedure: The phosphine ligand (PPh2R and PPhR2; R=Me or Et) (0.5mmol) was directly added to the solution of the starting complex [PtCl(sac)(COD)] (COD=1,5-cyclooctadiene) (0.25mmol, 0.13g) in the mixture of MeCN and MeOH (1:1, 10mL). The reaction mixture was refluxed for 24h. Then, the solvents were removed by a rotary evaporator and the white solids were washed with diethyl ether and a small amount of cold EtOH. The solids were dissolved in a mixture containing water, MeCN and MeOH (1:1:1). The crystals of 2, 3 and 4 were obtained from the evaporation of the solutions after three or four weeks at r.t., 607-01-2
Big data shows that 607-01-2 is playing an increasingly important role.
Reference£º
Article; Icsel, Ceyda; Yilmaz, Veysel T.; Cevatemre, Buse; Aygun, Muhittin; Ulukaya, Engin; Journal of Inorganic Biochemistry; vol. 195; (2019); p. 39 – 50;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate